Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma
Jiangqiao Zhou, Tao Qiu, Zhongbao Chen, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 511, Iss. 1, pp. 165-172
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

ASF1B promotes cervical cancer progression through stabilization of CDK9
Xinjian Liu, Jingwei Song, Yenan Zhang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 59
Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis
Leiming Wang, Xi Yang, Fei Zhou, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7197-7208
Open Access | Times Cited: 33
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Construction of Novel lncRNA–miRNA–mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma
Tian Zhan, Xiang Gao, Guoguang Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 34
Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
Xinyao Hu, Hua Zhu, Xiaoyu Zhang, et al.
Cancer Medicine (2021) Vol. 10, Iss. 19, pp. 6897-6916
Open Access | Times Cited: 34
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
Xiangyu Li, Ko Eun Shong, Woonghee Kim, et al.
EBioMedicine (2022) Vol. 78, pp. 103963-103963
Open Access | Times Cited: 22
ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
Wencheng Zhang, Zhouyong Gao, Mingxiu Guan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis
YunQiang Zhang, Mingyang Tang, Qiang Guo, et al.
Gene (2022) Vol. 816, pp. 146173-146173
Closed Access | Times Cited: 19
Elevated Expression of ASF1B Correlates with Poor Prognosis in Human Lung Adenocarcinoma
Zhenxing Feng, Jiao Zhang, Yafang Zheng, et al.
Personalized Medicine (2021) Vol. 18, Iss. 2, pp. 115-127
Closed Access | Times Cited: 23
ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer
Chuanzhi Chen, Haili Bao, Lin Wu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 6, pp. 1985-2000
Open Access | Times Cited: 16
ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
Shirong Zhang, Longwen Xu, Jinteng Feng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment
Jing Ma, Wei Han, Kai Lǚ
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer
Kun Wang, Zhiqiang Hao, Xibo Fu, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 7, pp. 1947-1957
Closed Access | Times Cited: 13
ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway
Wei Wang, Li‐Na Xiao, Deng Pan, et al.
Neoplasma (2022) Vol. 69, Iss. 02, pp. 361-369
Open Access | Times Cited: 12
Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma
Jiangqiao Zhou, Tianyu Wang, Tao Qiu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 17
MiR-148a-3p targets CEMIP to suppress the genesis of gastric cancer cells
Song Ming, Jun Liu, Xin Zheng, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 575, pp. 42-49
Closed Access | Times Cited: 15
Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
Peng Chen, Ziying Zhang, Xiang Chen
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 14
Genome-Wide Analysis Identifies NURR1-Controlled Network of New Synapse Formation and Cell Cycle Arrest in Human Neural Stem Cells.
Soo Min Kim, Soo Young Cho, Min Woong Kim, et al.
PubMed (2020) Vol. 43, Iss. 6, pp. 551-571
Closed Access | Times Cited: 13
Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA
Liya Huang, Ting Ye, Jingjing Wang, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 8
ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
Wei-Gang Qiu, Xinquan Wu, Haihong Shi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Identification of hsa_circ_0002024 as a prognostic competing endogenous RNA (ceRNA) through the hsa_miR_129-5p/Anti-Silencing Function 1B Histone Chaperone (ASF1B) axis in renal cell carcinoma
Zhe Chen, Dehua Ou, Zhuangkai Huang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6579-6593
Open Access | Times Cited: 11
The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma
Zifa Zhang, Shuming Liu
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1111-1122
Open Access | Times Cited: 4
ASF1B is an essential prognostic indicator linked to the growth and resistance characteristics of bladder cancer
Peng Zhang, Peng Wang, Yirong Wang
Tissue and Cell (2024) Vol. 89, pp. 102477-102477
Closed Access | Times Cited: 1
Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice
Xuemei Wang, Lu Wang, Jie Dou, et al.
Epigenetics & Chromatin (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 9
The molecular mechanism of novel oncogenes dysregulating signaling pathways associated with cervical carcinoma
Kaoutar Anouar Tadlaoui, Moulay Mustapha Ennaji
Elsevier eBooks (2023), pp. 19-31
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top